MDA and Antioxidants Status in Type 2 Diabetes Mellitus
Oxidative Stress in Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.70284/njirm.v4i6.2253Keywords:
Antioxidants, Diabetes Mellitus, Free radicals, Lipid peroxidation, MalondialdehydeAbstract
Background and Objectives: Diabetes mellitus (DM) refers to a group of common metabolic disorders that share the phenotype of hyperglycemia. Depending on the etiology of the Diabetes mellitus, factors contributing to hyperglycemia include reduced insulin secretion, decreased glucose utilization, and increased glucose production. In diabetes, oxidative stress seems caused by both increased production of ROS, sharp reduction in antioxidant defenses and altered cellular redox status. The purpose of this study was to evaluate the oxidative stress in type 2 diabetes mellitus. Methods: The study was conducted on 35 diabetic patients (11 Female /24 Male) with mean age of 52.8±5.4 years. Both the study groups were non-smokers and non-alcoholics and were not suffering from any other chronic disease. MDA and antioxidants status were estimated in both cases (35) and controls (30). Results: Plasma MDA levels in type 2 diabetic patients were found to be significantly higher (p<0.001) than controls, whereas levels of GPx, SOD, CAT, vitamin C and uric acid were significantly lower (p<0.001) in the diabetic patients compared to the control subjects. Conclusion: Diabetic patients were susceptible to oxidative stress and persistent hyperglycemia had an association with free radical-mediated lipid peroxidation. Our study suggests an imbalance between plasma oxidant and antioxidant system in type 2 diabetes mellitus.
References
2. Kuroki T, Isshiki K, King GL. Oxidative stress: The lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol 2003; 14: S216‑20.
3. Ahmad M, Khan MA, Khan AS. Naturally occurring antioxidant vitamin levels in patients with type‑II diabetes mellitus. J Ayub Med Coll Abbottabab 2003; 15: 54‑7.
4. Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 2000; 47: 457‑64.
5. Gorogawa S, Kajimoto Y, Umayahara Y, Kaneto H, Watada H, Kuroda A, et al. Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract 2002; 57: 1-10.
6. Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med 2005; 22: 674-82.7. Moussa SA. Oxidative stress in diabetes mellitus. Romanian J Biophys 2008; 18(3): 225-236.
8. Giugliano, D., Ceriello, A. and Paolisso, G. Oxidative stress and diabetic vascular complications. Diabetic Care 1996; 19: 257-267.
9. Trinder P. Estimation of blood glucose. Ann Clin Biochem 1969; 6: 24.
10. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: Biochemical roles as a component of glutathione peroxidase. Science 1973; 179: 588-90.
11. Sinha, KA. Colorimetric assay of catalase. Annal. Biochem 1972; 47: 389-394.
12. Kakkar, P., Das, B. and Viswanathan, P.N. A modified spectrophotometric assay of superoxide dimutase. Indian J. Biochem. Bio. Phys 1984; 21: 130-132.
13. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids 1978; 45: 337-51.
14. Roe JH, Kuther CA. Detection of ascorbic acid in whole blood and urine through the 2, 4, DNPH derivative of dehydroascorbic acid. J. Biol. Chem. 1943; 147: 399-401.
15. Rosenson RS. HDL-C and the diabetic patient: target for therapeutic intervention? Diabetes Res Clin Pract 2005; 68 Suppl 2: S36-42.
16. Sundaram RK, Bhaskar A, Vijayalingam S., Viswanathan, M., Mohan, R. and Shanmugasundaram , K. R. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996; 90: 255-60.
17. Yan H., Harding J.J. Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. Biochem J 1997; 328: 599–605.
18. Som S et al. Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981; 30: 572-577.
19. Stankova L et al. Plasma ascorbate concentrations and blood cell
dehydroascorbate transport in patients with DM. Metabolism 1984; 33: 347-353.
20. Ames, B N., Cathcart R., Schwier, E. & Hochstein P. Uric acid provides an antioxidant defense in human against oxidant and readical-caused aging and cancer: a hypothesis. Proc, Natl Acad. Sci. USA,1981; 18 : 6858-6862.
